Abstract
This study analyzes the body composition of young adult women with Turner syndrome (TS) either treated or not treated with recombinant human growth hormone (rhGH) and compares them with a group of healthy women. Fifty-two non-treated TS patients (23.0 ± 5.8 years), 30 treated with rhGH (21.5 ± 1.5 years), and 133 healthy young adult women (22.9 ± 3.2 years) were evaluated regarding height (H) and weight, body mass index (BMI), brachial perimeter and tricipital cutaneous fold (fat and lean areas at the arm), sitting height (SRH = sitting height/H × 100), leg length (leg/H), waist and hip circumferences (waist/hip), and bioimpedance (percentages of water, lean mass, and fat mass). Age at start of rhGH therapy varied from 7.8 to 15.1 years (10.0 ± 1.3 years), duration of treatment from 2.8 to 8.2 years (3.7 ± 1.5 years), and the mean dose was 0.42 mg/kg/w (from 0.32 to 0.50 mg/kg/w). Body composition (except height) did not differ between TS groups, but there were differences when compared to the control group: weight and sitting height were lower in TS patients; and BMI, SHR, and leg/H were higher. There was an association between all groups with regards to BMI, waist, SHR, and leg/H, but not in percentage of fat mass. SHR was positively correlated with BMI, waist, hip, and percentage of fat mass. This sample of TS patients (with and without rhGH therapy) did not differ in BMI or body composition. However, there were differences between patients with TS patients and normal healthy women. Regardless of rhGH therapy, TS patients should be monitored, particularly for sitting height, SHR, leg length, leg/H, and waist/hip.
Similar content being viewed by others
References
M.B. Ranke, P. Saenger, Turner’s syndrome. Lancet 358, 309–314 (2001)
M.B. Ranke, Growth in Turner’s syndrome. Acta Paediatr. 83, 343–344 (1994)
M.L. Davenport, N. Punyasavatsut, D. Gunther, L. Savendahl, P.W. Stewart, Turner syndrome: a pattern of early growth failure. Acta Paediatr. Suppl. 88, 118–121 (1999)
S.H. De Lemos-Marini, A.M. Morcillo, M.T. Baptista, G. Guerra-Jr, A.T. Maciel-Guerra, Spontaneous final height in Tuner′s syndrome in Brazil. J. Pediatr. Endocrionol. Metab. 20, 1207–1214 (2009)
C.A. Bondy, Turner Syndrome Study Group, Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J. Clin. Endocrinol. Metab. 92, 10–25 (2007)
V.K. Bakalov, M.M. Cooley, M.J. Quon, M.L. Luo, J.A. Yanovski, L.M. Nelson, Impaired insulin secretion in the Turner metabolic syndrome. J. Clin. Endocrinol. Metab. 89, 3516–3520 (2004)
T. Morgan, Turner syndrome: diagnosis and management. Am. Fam. Physician 76, 405–410 (2007)
C. Lichiardopol, M. Mota, D. Braicu, C. Militaru, F. Mixich, Diabetes mellitus and Turner syndrome. Rom. J. Intern. Med. 45, 299–304 (2007)
C.H. Gravholt, B.E. Hjerrild, L. Mosekilde, T.K. Hansen, L.M. Rasmussen, J. Frystyk, Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules. Eur. J. Endocrinol. 155, 583–592 (2006)
J. Lo, Does growth hormone therapy benefit body composition and glucose homeostasis in girls with Turner syndrome? Nat. Clin. Pract. Endocrinol. Metab. 4, 596–597 (2008)
M. Elsheikh, G.S. Conway, The impact of obesity on cardiovascular risk factors in Turner’s syndrome. Clin. Endocrinol. 49, 447–450 (1998)
P.R. Blackett, A.C. Rundle, J. Frane, S.L. Blethen, Body mass index (BMI) in Turner syndrome before and during growth hormone (GH) therapy. Int. J. Obes. Relat. Metab. Disord. 24, 232–235 (2000)
N. Wooten, V.K. Bakalov, S. Hill, C.A. Bondy, Reduced abdominal adiposity and improved glucose tolerance in growth hormone-treated girls with Turner syndrome. J. Clin. Endocrinol. Metab. 93, 2109–2114 (2008)
M. Ari, V.K. Bakalov, S. Hill, C.A. Bondy, The effects of growth hormone treatment on bone mineral density and body composition in girls with Turner syndrome. J. Clin. Endocrinol. Metab. 91, 4302–4359 (2006)
J.A. Delgado, C.M. Trahms, V.P. Sybert, Measurement of body fat in Turner syndrome. Clin. Genet. 29, 291–297 (1986)
T. Isojima, S. Yokoya, J. Ito, R. Horikawa, T. Tanaka, Inconsistent determination of overweight by two anthropometric indices in girls with Turner syndrome. Acta Paediatr. 98, 513–518 (2009)
A.R. Frisancho, New norms of upper limb fat and muscle areas for assessment of nutritional status. Am. J. Clin. Nutr. 34, 2540–2545 (1981)
R.F. Kuschner, Bioelectrical impedance analysis: a review of principles and applications. J. Am. Coll. Nutr. 11, 199–209 (1992)
E.C. Corrigan, L.M. Nelson, V.K. Bakalov, J.A. Yanovski, V.H. Vanderhoof, L.B. Yanoff, C.A. Bondy, Effects of ovarian failure and X-chromosome deletion on body composition and insulin sensitivity in young women. Menopause 13, 911–916 (2006)
F. Darendeliler, Z. Aycan, E. Cetinkaya, S. Vidilisan, F. Bas, A. Bideci, F. Demirel, Effects of growth hormone on growth, insulin resistance and related hormones (ghrelin, leptin and adiponectin) in Turner syndrome. Horm. Res. 68, 1–7 (2007)
C.H. Gravholt, R.W. Naeraa, Reference values for body proportions and body composition in adult women with Ulrich-Turner syndrome. Am. J. Med. Genet. 72, 403–408 (1997)
A.D. Baldin, T. Fabbri, A.A. Siviero-Miachon, A.M. Spinola-Castro, S.H.V. Lemos-Marini, M.T.M. Baptista, L.F.R. D’Souza-Li, A.T. Maciel-Guerra, G. Guerra-Junior, Effects of growth hormone on body proportions in Turner syndrome compared with non-treated patients and normal women. J. Endocrinol. Invest. 33, 691–695 (2010)
A.M. Ottesen, L. Aksglaede, J. Garn, N. Tartaglia, F. Tassane, C.H. Gravholt, A. Bojesen, K. Sorensen, J. Niels, E. Rajpert-de-Meyts, T. Gerdes, A.-M. Lind, S. Kjaergaard, A. Juul, Increased number of sex chromosomes affects height in nonlinear fashion: a study of 305 patients with sex chromosome aneuploidy. Am. J. Med. Genet. A 152A, 1206–1212 (2010)
G. Binder, Short stature due to SHOX deficiency: genotype, phenotype, and therapy. Horm. Res. Paediatr. 75, 81–89 (2011)
E.N.N. Bannink, R.L.F. van der Palsen, P.G.H. Mulden, Long-term follow-up of GH-treated girls with Turner syndrome: BMI, blood pressure, body proportions. Horm. Res. 71, 336–342 (2009)
L.A. Menke, T.C.I. Sas, G.R.I. Zandwjjken, M.A.I. de Ridder, T. Stjinen, S.M.P.F. de Munick Keizer-Schrama, B.J. Otten, J.M. Wit, The effect of oxandrolone on body proportions and body composition in growth hormone treated girls with Turner syndrome. Clin. Endocrinol. 73, 212–219 (2010)
L. Hagenäs, T. Hertel, Skeletal dysplasia, growth hormone treatment, body proportion: comparison with other syndromic and non-syndromic short children. Horm. Res. 60(suppl 3), 65–70 (2003)
B. Bogin, M.I. Varela-Silva, Leg length, body proportion, and health: a review with note on beauty. Int. J. Environ. Res. Public Health 7, 1047–1075 (2010)
Acknowledgments
The authors thank the National Council for Scientific and Technological Development (CNPq) for providing research fellowship (to GG-Jr) and the Coordination for Higher Level Graduates Improvement (CAPES) for providing doctoral scholarship (to ADB).
Conflicts of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Baldin, A.D., Fabbri, T., Siviero-Miachon, A.A. et al. Growth hormone effect on body composition in Turner syndrome. Endocrine 40, 486–491 (2011). https://doi.org/10.1007/s12020-011-9504-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-011-9504-z